Sagespring Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
46,596
-1,070
-2% -$249K 0.18% 69
2026
Q1
$11.7M Buy
47,666
+2,444
+5% +$569K 0.21% 63
2025
Q4
$9.36M Buy
45,222
+2,660
+6% +$526K 0.17% 71
2025
Q3
$7.89M Buy
42,562
+7,036
+20% +$1.21M 0.15% 76
2025
Q2
$5.43M Buy
35,526
+3,367
+10% +$518K 0.12% 95
2025
Q1
$5.33M Buy
32,159
+5,539
+21% +$867K 0.13% 82
2024
Q4
$3.85M Buy
+26,620
New +$4.13M 0.1% 97

Other funds holding JNJ

Sagespring Wealth Partners's JNJ Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, selling an estimated $249K and leaving 46,596 shares worth $11.8M. The position accounts for 0.18% of the portfolio, ranked #69.

Sagespring Wealth Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sagespring Wealth Partners held 46,596 shares of Johnson & Johnson worth $11.8M as of Q2 2026.
  • Sagespring Wealth Partners sold 1,070 Johnson & Johnson shares in Q2 2026, an estimated $249K.
  • Johnson & Johnson made up 0.18% of Sagespring Wealth Partners's portfolio in Q2 2026, its #69 holding.
  • Sagespring Wealth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.